Drug of Abuse Testing Services Market Growth & Trends [2031]

Drug of Abuse Testing Services Market Growth & Trends [2031]

Segments - Drug of Abuse Testing Services Market by Drug Types (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, Lysergic Acid Diethylamide, and Others) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-681 | 4.3 Rating | 60 Reviews | 180 Pages | Format : PDF Excel PPT

Report Description


Drug of Abuse Testing Services Market Outlook 2031:

The global drug of abuse testing services market size was valued at USD 3.10 Million in 2022 and is projected to reach USD 4.93 Million by 2031, expanding at a CAGR of 5.3% during the forecast period 2023 - 2031. The growth of this market is attributed to the rise in consumption of illegal drugs such as marijuana and cocaine along with the increasing number of clinical laboratories.

Drug of Abuse Testing Services Market Outlook

Governments are aware of the negative effects of drugs especially for under aged children and several organizational workplaces. They have introduced initiatives to combat and monitor the substance abuse present in their respective regions.

The United Nations Office of Drugs and Crime (UNODC) 2020 data shows that 40 million people uses several treatment to cure themselves from substance use disorders. The illicit drugs and alcohol causes addiction when used high amounts, which can therefore cause life threatening consequences.


Availability and access of treatment services globally is extremely limited to cure substance use disorders. In developed countries such as the US, the demand for substance use disorders treatment and healthcare centers are constantly increasing to combat this illness. The National Control Budget, US, has announced five key platforms for drug control functional namely prevention, treatment, interdiction, operation, and law enforcement.

This funding is estimated to reach nearly USD 36 billion by the end of 2021. The Substance Abuse and Mental Health Services Administration or the SAMHSA have received USD two billion for the substance use disorder prevention studies and other research processes. The US Department of Defense has also requested USD 1.5 billion for the constant monitoring of drug interaction operations and counterdrug actions in the country.

Drug of Abuse Testing Services Market Trends, Drivers, Restraints, and Opportunities

  • Growing number of clinics that offer drugs of substance use disorder testing services acts as a major driver for the drugs of abuse testing services market.
  • A major increase in clinical laboratories, hospitals, and other testing centers for the treatment of substance use disorder also contributes to the growth of this market.
  • High cost of laboratory screening diagnostics and rising use of disposable equipment are key restraining factors expected to hamper the market growth.
  • Rising awareness about the substance use disorders and introduction of several advanced treatment products or devices that can help to prevent this illness. This is projected to act as a key driver for the market.
  • The outbreak of COVID-19 pandemic has affected the market growth due to the strict lockdown protocols and putting halt in the distribution of the drugs freely from governments.

Scope of the Drug of Abuse Testing Services Market Report

The report on the global drug of abuse testing services market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attribute

Details

Report Title

Drug of Abuse Testing Services Market – Global Industry Analysis, Growth, Share, Size, Trends and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Drug Types (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, Lysergic Acid Diethylamide, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

Quest Diagnostics; Abbott Laboratories; Clinical Reference Laboratory (CRL), Inc; Laboratory Corporation of American Holdings; Cordant Health Solutions; Legacy Medical Services; DrugScan; Omega Laboratories, Inc; Psychemedics Corporation; Millennium Health; Mayo Clinic Laboratories; Precision Diagnostics; American Substance Abuse Professionals (ASAP), Inc; United States Drug Testing Laboratories (USDTL), Inc; and Laboratory of the Government Chemist (LGC) Group

 

Global Drug of Abuse Testing Services Market Segment Insights

Cannabis/Marijuana segment dominated the market with 27% in 2020

On the basis of drug types, the global drug of abuse testing services market is segmented into alcohol, cannabis/marijuana, cocaine, opioids, Amphetamine & Methamphetamine, Lysergic Acid Diethylamide (LSD), and others. The cannabis/marijuana segment held a large share of this market representing with 27% revenue share of the global market.

This segment is expected to dominate the market in the coming owing to wide abuse of cannabis or marijuana among a large number of adult population globally. The opioids segment is currently the second largest holding more than 22% share of the global market. The increasing opioid crisis in North America and Europe are the main reason for the large share of the opioid segment.

According to a survey conducted by the Drug Abuse Statistics in 2020, five million people have been reported to using cannabis or marijuana, out of which two million people are from the US alone.

Drug of Abuse Testing Services Market Drug Types

North America to account for a large share

Based on regions, the global drug of abuse testing services market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa North America is anticipated to account for a large market share in the coming years, which represented 39% share of the global market. The key factors attributing to the regional growth is the increasing awareness of the substance use disorder and the initiatives taken by various regional governments to monitor, control and combat it.

According to the National Control budget, the COVID-19 pandemic has increased the demand of the services and treatments of substance use disorder in North America. Meanwhile, the market in Asia Pacific is expected to exhibit a robust CAGR during the forecast period, 2021-2028.

Emerging economies such as India are now leveraging to spread awareness about the importance of substance use disorder treatments and several healthcare initiatives regarding the treatment. This is one of the major driving factors for the regional market growth.

 

Drug of Abuse Testing Services Market Region

Segments

The drug of abuse testing services market has been segmented in terms of

Drug Types

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • Lysergic acid Diethylamide (LSD)
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Quest Diagnostics
  • Abbott Laboratories
  • Clinical Reference Laboratory (CRL), Inc
  • Laboratory Corporation of American Holdings
  • Cordant Health Solutions
  • Legacy Medical Services
  • DrugScan
  • Omega Laboratories, Inc
  • Psychemedics Corporation
  • Millennium Health; Mayo Clinic Laboratories
  • Precision Diagnostics
  • American Substance Abuse Professionals (ASAP), Inc
  • United States Drug Testing Laboratories (USDTL), Inc
  • Laboratory of the Government Chemist (LGC) Group.

Competitive Landscape

Some of the key players in the global drug of abuse testing services market are Quest Diagnostics; Abbott Laboratories; Clinical Reference Laboratory (CRL), Inc; Laboratory Corporation of American Holdings; Cordant Health Solutions; Legacy Medical Services; DrugScan; Omega Laboratories, Inc; Psychemedics Corporation; Millennium Health; Mayo Clinic Laboratories; Precision Diagnostics; American Substance Abuse Professionals (ASAP), Inc; United States Drug Testing Laboratories (USDTL), Inc; and Laboratory of the Government Chemist (LGC) Group.

Many of these companies are constantly adopting different growth strategies including product development, expansion of geographical reach, and product differentiation. Companies also undergo mergers and acquisitions to have a competitive edge. Psychemedics Corporation, for instance, signed a new distribution agreement with Sansao Holding S.A and Toxicologia Pardini Ltda in Brazil. The former company now has access to the Brazilian distribution network of their drug of abuse testing services market.

 Drug of Abuse Testing Services Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug of Abuse Testing Services Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug of Abuse Testing Services Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug of Abuse Testing Services Market - Supply Chain
  4.5. Global Drug of Abuse Testing Services Market Forecast
     4.5.1. Drug of Abuse Testing Services Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug of Abuse Testing Services Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Drug of Abuse Testing Services Market Absolute $ Opportunity
5. Global Drug of Abuse Testing Services Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Drug of Abuse Testing Services Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
6. North America Drug of Abuse Testing Services Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Drug of Abuse Testing Services Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
7. Latin America Drug of Abuse Testing Services Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Drug of Abuse Testing Services Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
8. Europe Drug of Abuse Testing Services Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Drug of Abuse Testing Services Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
9. Asia Pacific Drug of Abuse Testing Services Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Drug of Abuse Testing Services Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
10. Middle East & Africa Drug of Abuse Testing Services Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Drug of Abuse Testing Services Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Drug of Abuse Testing Services Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Drug of Abuse Testing Services Market: Market Share Analysis
  11.2. Drug of Abuse Testing Services Distributors and Customers
  11.3. Drug of Abuse Testing Services Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Quest Diagnostics
     11.4.2. Abbott Laboratories
     11.4.3. Clinical Reference Laboratory (CRL), Inc
     11.4.4. Laboratory Corporation of American Holdings
     11.4.5. Cordant Health Solutions
     11.4.6. Legacy Medical Services
     11.4.7. DrugScan
     11.4.8. Omega Laboratories, Inc
     11.4.9. Psychemedics Corporation
     11.4.10. Millennium Health; Mayo Clinic Laboratori

Methodology

Our Clients

Dassault Aviation
Microsoft
General Mills
Honda Motor Co. Ltd.
FedEx Logistics
Nestle SA
sinopec
Pfizer